Indiana Spine Group is currently enrolling patients for the following clinical studies:
Treatment of Two-Level Symptomatic Cervical Disc Disease (SCDD): The purpose of the study is to evaluate the safety and effectiveness of prodisc® C SK and prodisc® C Vivo compared to Mobi-C®. Persons between 18 and 69 years of age, suffering from neck and arm pain due to cervical disc disease or think you might be, and have not responded to non-operative, conservative treatment. For more information about this study, visit ClinicalTrials.gov (Identifier NCT04012996) at https://clinicaltrials.gov/ct2/show/NCT04012996.
ASPIRE Trial- A STUDY TO EVALUATE AN INVESTIGATIONAL DEVICE FOR DEGENERATIVE DISC DISEASE
If you are one of the millions of Americans that suffer from Degenerative Disc Disease and non-surgical treatments, such as pain medication and physical therapy, fail to alleviate your symptoms, surgical options may be a path for relief. You could be eligible to participate in a research study if you:
Safety and Effectiveness of Bio2 Vitrium® Cervical Cage in Anterior Cervical Discectomy and Fusion. A Randomized, Controlled Non-inferiority, Pivotal Study
Intrinsic Therapeutics, Inc./Barricaid study: Prospective evaluation of Lumbar Discectomy with additional implantation of an annular closure device in patients with large postsurgical annular defects for prevention of lumbar disc reherniation.
Kuros Biosurgery A.G.: A prospective, randomized, controlled, single-blind, dose-finding, multi-center, parallel-group study of the safety and efficacy of KUR-113 Bone Graft (TGplPTH1-34 in fibrin) versus local autograft for the treatment of patients undergoing single-level transforaminal lumbar interbody fusion (the STRUCTURE study).
Discover: You may be eligible to participate if you are experiencing pain in a single leg that is associated with lumbar disc herniation which has not lasted for more than 12 months, are: 30 to 70 years of age, NOT in routine use of opioids/cannabis, < 35 of BMI, NOT receiving worker’s Compensation.
INFUSE TLIF study – Dr. Joseph Smucker, Dr. Paul Kraemer
A Prospective, Randomized, Controlled, Blinded Study In Subjects Undergoing A Transforaminal Lumbar Interbody Fusion (TLIF) At One Or Two Levels Using Infuse™ Bone Graft and The Capstone™ Spinal System with Posterior Supplemental Fixation For The Treatment Of Symptomatic Degenerative Disease Of The Lumbosacral Spine
INFUSE PLF study – Dr. Joseph Smucker, Dr. Paul Kraemer
A Prospective, Randomized, Multi-Center, Open-Label Pilot Study of Infuse® Bone Graft with Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion Treatment of Multi-Level Advanced Degenerative Disease of the Lumbosacral Spine (Infuse PLF Dosing Study)
Please contact Sheetal Vinayek, 317-715-5897, firstname.lastname@example.org, for more information about any of our current clinical studies we are enrolling patients for.